Business Seminar

 

Speaker:    Kenichi Higashino（Director and Head of the Corporate Planning Division, Shionogi Techno Advance Research Co., Ltd.）

Title:   What does “drug discovery” mean? 　～ Insights from SHIONOGI x STAR ～

 

 

Date&Time: 17 Oct. (Fri.) 2025,  15:00-16:30

Venue: 　Miyamoto Memorial Hall, Oe campus, Kumamoto University

 

Abstract:

Japan is one of the world’s leading countries in the development of new drugs. Not only does it contribute to medical care through the innovative drugs it creates, but the pharmaceutical industry also contributes to Japan’s economic growth through its stable tax-bearing capacity. However, compared to the rest of the world, Japan’s drug market is struggling to grow, raising concerns about drug loss. Furthermore, there are fears about the declining drug discovery capabilities of Japan’s pharmaceutical industry.
In this lecture, I would like to introduce the Shionogi Group, a domestic pharmaceutical company, to the students of Kumamoto University and those enrolled in the program. I will also present the current state of the pharmaceutical industry and the drug discovery process based on my experience in drug discovery research at Shionogi & Co., Ltd. and Shionogi Techno Advance Research Co., Ltd. I hope this serves as an opportunity to consider drug discovery research within companies and the future of drug discovery.

 

Email address for correspondance：　daigakuin-kyoiku[atmark]jimu.kumamoto-u.ac.jp （[atmark]→@）